| Bioactivity | Fedovapagon (VA106483) is a selective and orally active vasopressin V2 receptor (V2R) agonist with an EC50 of 24 nM. Fedovapagon can be used in the research of nocturia[1]. |
| In Vivo | Fedovapagon (1 mg/kg, oral administration) inhibits urine output with 81% inhibition rate in rats[1]. Animal Model: |
| Name | Fedovapagon |
| CAS | 347887-36-9 |
| Formula | C27H34N4O3 |
| Molar Mass | 462.58 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |
| Reference | [1]. Yea CM, et al. New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists. J Med Chem. 2008 Dec 25;51(24):8124-34. |
Fedovapagon
CAS: 347887-36-9 F: C27H34N4O3 W: 462.58
Fedovapagon (VA106483) is a selective and orally active vasopressin V2 receptor (V2R) agonist with an EC50 of 24 nM. Fed
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.